About: WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

retracted scientific article published on 07 September 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2018 (uk) article scientifique publié en 2018 (fr) artículu científicu espublizáu en setiembre de 2018 (ast) im Dezember 2018 veröffentlichter wissenschaftlicher Artikel (de) retracted scientific article published on 07 September 2018 (en)
publication date	wds:Q62667736-DDB25565-DE62-44A3-A864-8682EAD496A7
publication date	2018-09-07 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q62667736-24E8ED8E-993C-401A-BD1A-91F49AD75C84
language of work or name	English
cites work	wds:Q62667736-06320D11-1330-4A67-982C-1304D11A7F46 wds:Q62667736-290F6022-D5B1-4F33-8A7C-60A9C2CA75A0 wds:Q62667736-3E96345D-F9DF-4C3A-9942-359168F399DE wds:Q62667736-553564E0-E1C6-45B5-B188-FECF61C41754 wds:Q62667736-5AC8757A-C766-46CC-A582-6E65B3AF5566 wds:Q62667736-5EB59BFA-A927-4D21-8B24-7D6885AB7C4A wds:Q62667736-60C1DA71-D9AB-4A72-9361-A9C667EDD2EC wds:Q62667736-7EA42F8F-0E38-4573-B5C1-A5A0F7D2BF4A wds:Q62667736-84DF9386-EB63-4536-9D40-FAFB87033C0B wds:Q62667736-A0EB8600-62C9-43B8-AA67-6724807FAD2B wds:Q62667736-B0FCFAE0-D1A2-4A8B-9700-A25CAC154D7B wds:Q62667736-BDCC27E6-EDF6-4D05-8A22-181EDECCCF7C wds:Q62667736-C1FC44AE-1143-4376-8A02-4FA308140343 wds:Q62667736-D10F4D24-6A23-4D7B-97CE-03472760A002 wds:Q62667736-DD19ED05-AD28-406F-9C2F-A7719B5EC18C wds:Q62667736-E54182C0-CEAD-4CF4-A45F-9D6CA3CA66B5 wds:Q62667736-ED1DC823-CBA0-4152-AA42-5BD9BC59A7AF wds:Q62667736-F34C6B77-5979-47CA-B4CF-BE9D8833355F wds:Q62667736-F5E71DA7-1A90-40AF-B4B5-03DB493962E0 wds:Q62667736-F6A221B7-A247-4234-AB48-31C4EC678EFB wds:Q62667736-F7C2CAA5-9793-4B40-A52F-7842D542274D
cites work	Current strategies and future trends in immunosuppression after heart transplantation Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy The clinical spectrum of pulmonary aspergillosis Infectious complications after heart transplantation Cytomegalovirus infection in transplant recipients Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody The immunological function of CD52 and its targeting in organ transplantation Alemtuzumab (Campath-1H) in kidney transplantation Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients Cytomegalovirus infections in solid organ transplantation: a review Five-year outcomes with alemtuzumab induction after lung transplantation Evaluation of Alemtuzumab Versus Basiliximab Induction: A Retrospective Cohort Study in Lung Transplant Recipients Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis. Impact of Immune-Modulatory Drugs on Regulatory T Cell Infections after lung transplantation: time of occurrence, sites, and microbiologic etiologies Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation. Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients
author name string	wds:Q62667736-2D115AE7-ECED-4EA5-B4E5-A718B89E3DE5 wds:Q62667736-5443BC70-3780-4078-B5DB-8C358C1C00FD wds:Q62667736-564FBF39-EA06-428C-BBE1-D5D1DBB87F40 wds:Q62667736-5B08B185-C8C6-4B50-930F-D0C407973816 wds:Q62667736-A6A399C3-B501-4ABB-B4B8-CD6B197A82C2 wds:Q62667736-AA60FEED-F4F5-49D4-8083-0E835DD0E673 wds:Q62667736-BAC96AAD-1AF5-4F24-97B9-C61D7344E260 wds:Q62667736-D708E991-9BC9-4CE7-877C-0DD981E0A195 wds:Q62667736-D7FCBD87-DB53-4C6E-8EE7-8A1C4A9F4B21 wds:Q62667736-F4301ADF-8305-4C51-BC45-4619BDE7A06A wds:Q62667736-F5E4427B-2745-4093-9E78-D7A4D844B760
author name string	G Li M Gong T Liu Y Xia J Ho W K K Wu M Dong International Health Informatics Study (IHIS) Network B Recaldin J C S Ho K H C Li
rdfs:label	WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis (en) WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis (nl)
skos:prefLabel	WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis (en) WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis (nl)
name	WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis (en) WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis (nl)
author	wds:Q62667736-A593562A-2C51-408D-A2C0-83DF1598F591 wds:Q62667736-C69665E4-637F-4B08-84D1-053A6A111379
author	Gary Tse Martin Chi-Sang Wong
title	wds:Q62667736-757FE32D-50BF-44C6-A379-5D8CDCE311B5
title	WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis (en)
page(s)	wds:Q62667736-0C3F4A2F-5485-41B7-987B-FB7E89BB7F53
page(s)	3739-3747
instance of	wds:Q62667736-03877718-AA0E-41DB-A606-BA14138E1532 wds:Q62667736-AA710334-48A6-4500-A0E5-2A915F5C6DA1
instance of	scholarly article retracted paper
PubMed ID	wds:Q62667736-F5A28C1A-7704-4077-8BE4-5F10B03C42AA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30577265
PubMed ID	30577265
published in	wds:Q62667736-0269733C-7555-4061-ABDD-90F17A3AED97
published in	Transplantation Proceedings
issue	wds:Q62667736-BD42EF51-164D-4B84-B140-573EE9BD0CDD
volume	wds:Q62667736-448B3CF8-B9C8-4846-8B3E-8388B28A329E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software